total number of worldwide allowed, granted or issued patents held by the Vycor Group to 20, with a further 31 patents pending.
The previously announced allowance for issuance for China Patent No. ZL200680056889.9 has been granted. This action provides Vycor patent rights with respect to its innovative ViewSite Brain Access System (VBAS) in China, a key strategic market for the Company. Vycor is in the closing stages of its China SFDA process which will enable it to commence sales of VBAS in China.
The previously announced allowance for issuance for China Patent No. ZL200680056889.9 has been granted. This action provides Vycor patent rights with respect to its innovative ViewSite Brain Access System (VBAS) in China, a key strategic market for the Company. Vycor is in the closing stages of its China SFDA process which will enable it to commence sales of VBAS in China.
Recent VYCO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 07:42:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 06:53:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 07:31:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 06:35:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 04:48:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 03:10:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 05:40:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 02:17:28 PM
